Estrella Immunopharma Stock (NASDAQ:UPTD)

Ownership Financials Chart

Previous Close

$9.96

52W Range

$6.88 - $33.00

50D Avg

$10.12

200D Avg

$10.52

Market Cap

$20.25M

Avg Vol (3M)

$558.16K

Beta

0.12

Div Yield

-

UPTD Company Profile

TradeUP Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses. It intends to focus its search on companies in the technology industry. The company was incorporated in 2021 and is based in New York, New York.

Industry

Shell Companies

Sector

Financial Services

Exchange

NASDAQ

ADR

-

Country

US

Employees

-

IPO Date

Sep 14, 2021

Website

-

UPTD Performance

UPTD Financial Summary

	Dec 22	Jun 22	Jun 21
Revenue	-	-	-
Operating Income	$-1.57M	$-1.69M	$-733.69K
Net Income	$-996.10K	$-1.69M	$-733.69K
EBITDA	$-1.57M	$-1.69M	$-733.69K
Basic EPS	$-0.17	$-0.29	$-0.02
Diluted EPS	$-0.17	$-0.29	$-0.02

Fiscal year ends in Dec 22 | Currency in USD

Peer Comparison

Ticker	Company
DTOC	American Oncology Network, Inc.
PNAC	Prime Number Acquisition I Corp.
LGVC	LAMF Global Ventures Corp. I
LBBB	Lakeshore Acquisition II Corp.
ITAQ	Industrial Tech Acquisitions II, Inc.
FLFV	Feutune Light Acquisition Corporation
BHAC	Crixus BH3 Acquisition Company
CPAA	Advantage Solutions Inc.
BLAC	Bellevue Life Sciences Acquisition Corp.